Outcome and Salvage Surgery Following "Watch and Wait" for Rectal Cancer after Neoadjuvant Therapy: A Systematic Review
- PMID:28177997
- DOI: 10.1097/DCR.0000000000000754
Outcome and Salvage Surgery Following "Watch and Wait" for Rectal Cancer after Neoadjuvant Therapy: A Systematic Review
Abstract
Background: Currently there is no reliable test to predict pathological complete response following neoadjuvant chemoradiotherapy for rectal cancer. However, there is increasing interest in using clinical complete response as a surrogate marker, allowing a subset of patients with locally advanced rectal cancer to be allocated into a "watch and wait" pathway. Little is known about the oncological safety of the "watch and wait" approach or the rate of salvage surgery in cases of tumor regrowth. This information is critical for the implementation of this approach.
Objective: The aim of this study is to assess the rate of salvage surgery and associated oncological outcomes for patients who develop a tumor regrowth with the "watch and wait" approach.
Data sources: Relevant studies were identified through PubMed, Embase, and Google Scholar search.
Study selection: A systematic review was undertaken of studies assessing patients selected for the "watch and wait" approach according to PRISMA guidelines.
Main outcome measures: The associated tumor regrowth, salvage surgery, and disease-free and overall survival rates were assessed.
Results: Five retrospective and 4 prospective observational studies were included into the analysis, with a total of 370 patients in the "watch and wait" group, of which 256 (69.2%) had persistent clinical complete response. Of those who had tumor regrowth, salvage surgery was possible in 83.8%. There was no difference in overall survival and disease-free survival between patients who received immediate surgery and the "watch and wait" group.
Limitations: The limitations of this study include its retrospective nature and small sample size. Furthermore, there is significant heterogeneity between study protocols, including the short median follow-up, given that tumor regrowth and distant metastasis may manifest at a later time point.
Conclusion: The majority of patients with tumor regrowth can be salvaged with definite surgery after "watch and wait." However, there is insufficient evidence to draw firm conclusions on the oncological safety of this approach; therefore, it is currently not the standard of care for locally advanced rectal cancer.
Similar articles
- A watch-and-wait approach for locally advanced rectal cancer after a clinical complete response following neoadjuvant chemoradiation: a systematic review and meta-analysis.Dossa F, Chesney TR, Acuna SA, Baxter NN.Dossa F, et al.Lancet Gastroenterol Hepatol. 2017 Jul;2(7):501-513. doi: 10.1016/S2468-1253(17)30074-2. Epub 2017 May 4.Lancet Gastroenterol Hepatol. 2017.PMID:28479372Review.
- Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis.Renehan AG, Malcomson L, Emsley R, Gollins S, Maw A, Myint AS, Rooney PS, Susnerwala S, Blower A, Saunders MP, Wilson MS, Scott N, O'Dwyer ST.Renehan AG, et al.Lancet Oncol. 2016 Feb;17(2):174-183. doi: 10.1016/S1470-2045(15)00467-2. Epub 2015 Dec 17.Lancet Oncol. 2016.PMID:26705854
- Conditional recurrence-free survival of clinical complete responders managed by watch and wait after neoadjuvant chemoradiotherapy for rectal cancer in the International Watch & Wait Database: a retrospective, international, multicentre registry study.Fernandez LM, São Julião GP, Figueiredo NL, Beets GL, van der Valk MJM, Bahadoer RR, Hilling DE, Meershoek-Klein Kranenbarg E, Roodvoets AGH, Renehan AG, van de Velde CJH, Habr-Gama A, Perez RO; International Watch & Wait Database Consortium.Fernandez LM, et al.Lancet Oncol. 2021 Jan;22(1):43-50. doi: 10.1016/S1470-2045(20)30557-X. Epub 2020 Dec 11.Lancet Oncol. 2021.PMID:33316218
- [Outcome of watch and wait strategy or organ preservation for rectal cancer following neoadjuvant chemoradiotherapy: report of 35 cases from a single cancer center].Wu A, Wang L, Du C, Peng Y, Yao Y, Zhao J, Zhan T, Cai Y, Li Y, Sun Y, Ji J.Wu A, et al.Zhonghua Wei Chang Wai Ke Za Zhi. 2017 Apr 25;20(4):417-424.Zhonghua Wei Chang Wai Ke Za Zhi. 2017.PMID:28440523Chinese.
- 'Watch and wait' after chemoradiotherapy for rectal cancer.Mullaney TG, Lightner AL, Johnston M, Keck J, Wattchow D.Mullaney TG, et al.ANZ J Surg. 2018 Sep;88(9):836-841. doi: 10.1111/ans.14352. Epub 2018 Jul 25.ANZ J Surg. 2018.PMID:30047201Review.
Cited by
- Neoadjuvant Therapy for cT2N0M0 Rectal Cancer?Rubio GA, Hurst RD, Umanskiy K, Shogan BD, Hyman N, Olortegui KS.Rubio GA, et al.J Gastrointest Surg. 2022 Feb;26(2):479-482. doi: 10.1007/s11605-021-05125-8. Epub 2021 Sep 10.J Gastrointest Surg. 2022.PMID:34506020No abstract available.
- Radical surgery versus organ preservation via short-course radiotherapy followed by transanal endoscopic microsurgery for early-stage rectal cancer (TREC): a randomised, open-label feasibility study.Bach SP, Gilbert A, Brock K, Korsgen S, Geh I, Hill J, Gill T, Hainsworth P, Tutton MG, Khan J, Robinson J, Steward M, Cunningham C, Levy B, Beveridge A, Handley K, Kaur M, Marchevsky N, Magill L, Russell A, Quirke P, West NP, Sebag-Montefiore D; TREC collaborators.Bach SP, et al.Lancet Gastroenterol Hepatol. 2021 Feb;6(2):92-105. doi: 10.1016/S2468-1253(20)30333-2. Epub 2020 Dec 11.Lancet Gastroenterol Hepatol. 2021.PMID:33308452Free PMC article.Clinical Trial.
- Meta-analysis of the prognostic value of CpG island methylator phenotype in rectal cancer.Kokelaar RF, Jones H, Beynon J, Evans ME, Harris DA.Kokelaar RF, et al.Int J Colorectal Dis. 2018 Aug;33(8):995-1000. doi: 10.1007/s00384-018-3108-5. Epub 2018 Jun 20.Int J Colorectal Dis. 2018.PMID:29926233Free PMC article.Review.
- Nonoperative Management of dMMR/MSI-H Colorectal Cancer following Neoadjuvant Immunotherapy: A Narrative Review.Xiao B, Yu J, Ding PR.Xiao B, et al.Clin Colon Rectal Surg. 2023 Apr 9;36(6):378-384. doi: 10.1055/s-0043-1767703. eCollection 2023 Nov.Clin Colon Rectal Surg. 2023.PMID:37795463Free PMC article.Review.
- Radiotherapy management of rectal cancer in the backdrop of the COVID pandemic.Lewis S, Talapatra K.Lewis S, et al.Cancer Rep (Hoboken). 2021 Apr;4(2):e1320. doi: 10.1002/cnr2.1320. Epub 2020 Dec 9.Cancer Rep (Hoboken). 2021.PMID:33295140Free PMC article.Review.
Publication types
MeSH terms
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources